These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6947720)

  • 61. [Reactivity of monoclonal antibodies in cytotoxicity and immunofluorescence tests].
    Koubek K
    Cas Lek Cesk; 1982 Nov; 121(44):1359-63. PubMed ID: 6756637
    [No Abstract]   [Full Text] [Related]  

  • 62. Monoclonal antibodies as enhancers of the host's immunoresponse against the tumour.
    Mellstedt H
    Ann Oncol; 2000; 11 Suppl 3():191-4. PubMed ID: 11079140
    [No Abstract]   [Full Text] [Related]  

  • 63. [Immunologic manifestations in the serum of patients with malignant diseases].
    Konopík J; Chaloupecká P; Kohout P; Jakoubková J; Lintner L
    Cesk Dermatol; 1975 Jun; 50(3):169-73. PubMed ID: 1139664
    [No Abstract]   [Full Text] [Related]  

  • 64. Liposomes as aids to tumour detection.
    Barratt GM; Ryman BE; Chester KA; Begent RH
    Biochem Soc Trans; 1984 Apr; 12(2):348-9. PubMed ID: 6724123
    [No Abstract]   [Full Text] [Related]  

  • 65. Antibodies against osteosarcoma and colon cancer.
    Embleton MJ; Brown A; Gunn B; Byers VS; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):35-8. PubMed ID: 6591916
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
    Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
    Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
    [No Abstract]   [Full Text] [Related]  

  • 67. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
    Price MR; Pimm MV; Baldwin RW
    Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Engineering mouse monoclonal antibodies for cancer immunotherapy.
    Orlandi R
    Year Immunol; 1993; 7():69-73. PubMed ID: 8372514
    [No Abstract]   [Full Text] [Related]  

  • 70. Characteristics of two anti-tumour monoclonal antibody preparations.
    Price MR; Dennick RG; Fang CY; Hannant D; Embleton MJ; Gunn B; Baldwin RW
    Arch Geschwulstforsch; 1981; 51(4):302-9. PubMed ID: 6947720
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.